Repeat cytoreduction with Hyperthermic Intraperitoneal chemotherapy in patients with peritoneal disease: A 5-year retrospective analysis.
João MendesSónia MarquesMariana PeyroteoMercês LoboFernanda SousaManuel FernandesJosé Flávio VideiraAbreu de Sousa
Published in: Surgical oncology (2024)
Repeat CR-HIPEC is a safe approach with an acceptable complication rate for its complexity, associated with a survival benefit in selected patients. It should be presented as a valid therapeutic option in recurrent peritoneal disease.